March 29, 2023 Published on Endpoints News A handful of CDMOs have made changes at the top over the past few weeks, including Genezen and Curia. That also includes Australian CDMO BioCina, which announced last week that Mark Womack would be taking the helm. Womack previously served as chief business officer at AGC Biologics, CEO […]

June 20, 2022 Published in Sunday Mail, by Brad Crouch Excerpts copied below. Read the full article in Sunday Mail at the link at the bottom of the page. A new Covid-19 vaccine designed and manufactured in Adelaide starts human trials this week with potential to become a major export earner – and it doesn’t […]

(SAN DIEGO and ADELAIDE April 5, 2022) BioCina, a leading contract development and manufacturing organization (CDMO) is pleased to announce that it has been awarded a $3.0m AUD grant under the Federal Government’s Cooperative Research Centres Projects (CRC-P) Grants scheme to fund work with its industry partners to further develop RNA vaccines and therapeutics. The grant has […]

(San Diego, June 30, 2021) BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics announces today the appointment of Sven Lee to the Board of Directors. BioCina is recognized for delivering high-quality, cost effective microbial process development and manufacturing solutions, leveraging a team of multi-disciplinary […]